Ranbaxy in $500 Million Settlement of Generic Drug Case
The generic drug maker Ranbaxy pleaded guilty on Monday to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold subpar drugs and made false statements to the Food and ... Read more